These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5609718)

  • 21. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The therapeutic value of anabolic steroids in gastroenterology].
    Demole M
    Schweiz Med Wochenschr; 1966 Mar; 96(9):291-6. PubMed ID: 5983996
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ineffective measures in the therapy of hepatobiliary diseases].
    Strohmeyer G
    Z Gastroenterol Verh; 1984 Apr; 19():128-33. PubMed ID: 6203240
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of the short-term treatment of active chronic liver diseases with betamethasone].
    Sarti F; Milandri GL; Giuliani Piccari G; Formica G; Spongano P; Accardo P
    G Clin Med; 1982 Jun; 63(6):392-400. PubMed ID: 6816654
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
    Gasbarrini G; Bernardi M
    Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G; Boda Z; Dalmi L; Weisz G; Misz M; Beck P
    Ther Hung; 1984; 32(1):19-25. PubMed ID: 6571189
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use in ophthalmology of betamethasone disodium phosphate].
    Boschetti G
    Minerva Oftalmol; 1966; 8(5):172-4. PubMed ID: 5991429
    [No Abstract]   [Full Text] [Related]  

  • 29. [Betamethasone phosphate in dermatology (Betnesol)].
    Témime P; Privat Y
    Bull Soc Fr Dermatol Syphiligr; 1965; 72(3):274-5. PubMed ID: 5842186
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
    Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
    Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
    [No Abstract]   [Full Text] [Related]  

  • 31. [Betamethasone phosphate administered locally in some otorhinolaryngologic diseases].
    Russo C
    Ann Laringol Otol Rinol Faringol; 1966; 65(2):277-85. PubMed ID: 5952882
    [No Abstract]   [Full Text] [Related]  

  • 32. [Local injections of betamethasone phosphate in rheumatologic practice].
    Berato J; Commandre F; Santarelli
    Mars Med; 1965; 102(11):917-20. PubMed ID: 5295241
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical trials and importance of betamethasone phosphate in otorhinolaryngology].
    Rivasseau J
    Rev Laryngol Otol Rhinol (Bord); 1967; 88(7):624-6. PubMed ID: 5618491
    [No Abstract]   [Full Text] [Related]  

  • 34. [Betamethasone phosphate in otorhinolaryngologic diseases].
    Bouche J; Bruker J
    Rev Laryngol Otol Rhinol (Bord); 1965; 86(9):794-800. PubMed ID: 5851577
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of corticoids on urinary excretion of calcium, inorganic phosphates and hydroxyproline].
    Caniggia A; Gennari C; Bencini M; Palazzuoli V; Cesari L; Borrello G; Bissanti A
    Minerva Med; 1969 Jan; 60(6):165-70. PubMed ID: 5776764
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of hepatic diseases with alpha-mercaptopropionylglycine].
    De Pergola E; Carrozzini B; Selvaggio G; De Pergola G
    Minerva Med; 1982 May; 73(19):1297-9. PubMed ID: 7078808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Betamethasone sodium phosphate.
    Nurs Times; 2004 Dec 7-13; 100(49):43. PubMed ID: 15630973
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L; Orlando R; Lirussi F; Naccarato R; Dal Brun G
    Clin Ter; 1980 May; 93(4):431-8. PubMed ID: 6998643
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of the use of a new synthetic corticoid: betamethasone phosphate].
    Gaubert ; Couture ; Jeanneton ; Demichel
    J Med Bord; 1965 Jun; 142(6):1108-14. PubMed ID: 5839538
    [No Abstract]   [Full Text] [Related]  

  • 40. [The therapy of neonatal jaundice with oral administration of betamethasone phosphate (Bentalon)].
    Vignolo Lutati U; Gavinelli R; Cappetti CA
    Minerva Pediatr; 1966 Nov; 18(33):1948-9. PubMed ID: 5997815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.